EYEGATE PHARMACEUTICALS INC's ticker is EYEG and the CUSIP is 30233M107. A total of 23 filers reported holding EYEGATE PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $4,275,000 | -21.3% | 17,812,500 | 0.0% | 0.27% | -9.1% |
| Q1 2019 | $5,433,000 | -32.3% | 17,812,500 | +3.2% | 0.30% | -51.2% |
| Q4 2018 | $8,029,000 | +54.1% | 17,262,853 | +2.7% | 0.61% | +94.6% |
| Q3 2018 | $5,209,000 | -41.5% | 16,802,500 | 0.0% | 0.31% | -46.1% |
| Q2 2018 | $8,905,000 | +1865.8% | 16,802,500 | +1309.6% | 0.58% | +1560.0% |
| Q1 2018 | $453,000 | -67.0% | 1,192,000 | -7.2% | 0.04% | -74.5% |
| Q4 2017 | $1,374,000 | -27.3% | 1,284,000 | -20.5% | 0.14% | -38.6% |
| Q3 2017 | $1,891,000 | -14.6% | 1,616,000 | 0.0% | 0.22% | -20.9% |
| Q2 2017 | $2,214,000 | – | 1,616,000 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 16,802,500 | $5,209,000 | 0.31% |
| WEDBUSH SECURITIES INC | 20,000 | $6,000 | 0.00% |
| US BANCORP \DE\ | 40,650 | $13,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 100 | $0 | 0.00% |
| NORTHERN TRUST CORP | 14,553 | $5,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 44,270 | $14,000 | 0.00% |
| PANAGORA ASSET MANAGEMENT INC | 107,430 | $33,000 | 0.00% |
| MORGAN STANLEY | 5,000 | $2,000 | 0.00% |
| Invesco Ltd. | 10,323 | $3,000 | 0.00% |